局灶性与弥漫性子宫腺肌病保留生育功能手术后的生殖结局:一项系统综述
该系统综述纳入18项研究、1396例不孕的局灶性或弥漫性子宫腺肌病患者,评估保留生育功能手术后的生殖结局。局灶性患者平均妊娠率52.7%、流产率21.1%,弥漫性患者分别为34.1%和21.7%;弥漫性患者子宫破裂发生率为6.8%(3/44),局灶性为0%(0/35)。局灶性患者术后妊娠率似乎高于弥漫性患者,但显著异质性妨碍直接比较,需前瞻性对照试验进一步阐明。
要点
- 局灶性子宫腺肌病保留生育手术后平均妊娠率52.7%,弥漫性为34.1%。
- 弥漫性患者子宫破裂发生率为6.8%(3/44),局灶性为0%(0/35)。
- 显著异质性妨碍直接比较,需前瞻性对照试验进一步阐明获益。
核心结论
- 局灶性子宫腺肌病患者保守手术后妊娠率似乎高于弥漫性患者,而弥漫性患者术后子宫破裂发生率更高。
- 显著异质性妨碍任何直接比较,需前瞻性对照试验进一步阐明保留生育功能手术相对于药物或期待治疗对子宫腺肌病相关不孕的获益。
研究设计与样本
- 系统综述,纳入18项研究、1396例不孕的局灶性或弥漫性子宫腺肌病患者。
主要发现
- 局灶性子宫腺肌病患者平均妊娠率为52.7%(范围14.3%-77.5%),平均流产率为21.1%(范围0%-44.4%)。
- 弥漫性子宫腺肌病患者平均妊娠率为34.1%(范围9.4%-100%),平均流产率为21.7%(范围12.5%-33.3%)。
- 弥漫性子宫腺肌病妊娠患者中子宫破裂发生率为6.8%(3/44)、早产发生率为4.5%(2/44),局灶性患者分别为0%(0/35)和10.9%(12/110)。
- 自然受孕与辅助生殖技术(伴或不伴促性腺激素释放激素激动剂预处理)之间未观察到显著差异。
临床怎么用
- 鉴于保守手术获益存在争议且不良妊娠结局可能增加(尤其弥漫性子宫腺肌病),临床医生应个体化考虑手术。
- 作者认为手术可能适用于合并子宫腺肌病相关盆腔痛或月经过多的女性、药物治疗失败的不孕年轻女性或 despite ART 仍不孕的年长女性,以及有复发性流产或种植失败史者。
局限性
- 显著异质性妨碍任何直接比较。
- 需前瞻性对照试验进一步阐明保留生育功能手术相对于药物或期待治疗对子宫腺肌病相关不孕的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Among the variety of treatment options to improve reproductive outcomes for infertile women with adenomyosis (AD), uterine-conserving surgery has shown varying success. Hence, we conducted a systematic review around the topic of fertility-sparing surgery across 18 studies and 1396 infertile women with focal and diffuse AD. Patients with focal AD showed mean pregnancy and miscarriage rates of 52.7% (range,14.3%-77.5%) and 21.1% (range, 0%-44.4%), respectively, whereas patients with diffuse AD had mean pregnancy and miscarriage rates of 34.1% (range, 9.4%-100%) and 21.7% (range, 12.5%-33.3%), respectively. Uterine rupture and preterm birth were observed in 6.8% (3/44) and 4.5% (2/44) of pregnant patients with diffuse AD versus 0% (0/35) and 10.9% (12/110) of patients with focal AD, respectively. No significant differences were observed between natural conception versus assisted reproductive technology (ART) with or without gonadotropin-releasing hormone agonist pretreatment. Overall, patients with focal AD appeared to have higher pregnancy rates after conservative surgery compared with diffuse AD, whereas a higher incidence of uterine rupture was reported after surgery for diffuse AD. However, significant heterogeneity precludes any direct comparison, and prospective controlled trials are required to further elucidate the benefits of fertility-preserving surgery over medical or expectant management for AD-related infertility. In view of the debatable benefits of conservative surgery and the possible increase in adverse pregnancy outcomes, particularly in cases of diffuse AD, clinicians should consider surgery on a case-by-case basis because it may be appropriate for women with concurrent AD-associated pelvic pain or menorrhagia, younger infertile women who have failed medical management or older women with infertility despite ART, and those with a history of recurrent pregnancy loss or implantation failure.
引用
- Tan J, Moriarty S, Taskin O, et al. Reproductive Outcomes after Fertility-Sparing Surgery for Focal and Diffuse Adenomyosis: A Systematic Review. J Minim Invasive Gynecol. 2018. PMID: 29305234. doi:10.1016/j.jmig.2017.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。